Cardiovascular Care

TISARTIN-TRIO

Telmisartan 40 mg + Amlodipine 5 mg + Hydrochlorothiazide 12.5 mg

Tablet 3D representation
Medicine Type:Tablet Type360°
Cardiovascular Care
Tablet

TISARTIN-TRIO

DECAGON PHARMACEUTICALS

Dosage Form
Tablet
Packaging
10 x 10 Tablets / Blister Pack
Contact Medical Representative
Product Introduction

Overview of TISARTIN-TRIO

TISARTIN-TRIO is a triple combination antihypertensive tablet combining Telmisartan (40 mg), Amlodipine (5 mg), and Hydrochlorothiazide (12.5 mg). Scientifically designed for aggressive blood pressure control in patients requiring multi-pathway hemodynamic reduction to protect vital organs and prevent cardiovascular events.

Designed For / Target Audience

Indicated for severe or stage 2 essential hypertension, patients not adequately controlled on dual therapy or monotherapy, and individuals at elevated risk of stroke and heart failure.

Suitable Scientific Claim for Promotional Literature

"A Triple Combination for Aggressive BP Control — With Healthier Lifeline."

Clinical Evidence Context: Key Indications: Severe hypertension, patients uncontrolled on dual therapy, and hypertensive patients requiring multi-organ protection.

Therapeutic Category

Cardiovascular Care

Dosage Form & Delivery

Tablet

Disclaimer: TISARTIN-TRIO is a prescription antihypertensive medication. To be used strictly under medical supervision.